Brought to you by:
Powered by wagescape.com
Labor Market Pulse
Albany-Schenectady-Troy, NY Metro Edition
Focus: LIFE SCI
-250/month avg
Metro job growth
2026 pace vs +267/month average in 2025
23,643 jobs
NY pharma/biotech employment
Record high as of August 2026, statewide
-39% YoY
BioSpace posting volume
September 2026, signals selective hiring statewide
3.9%
Albany County unemployment
vs 4.1% national rate, August 2026
This Month's Takeaways
Albany's overall job growth has nearly stalled, yet Validation Engineer and Clinical Research Associate pay both moved up significantly against national medians. Headcount planning should separate general metro conditions from the narrower, tighter market for execution-critical scientific roles.
Metro Regulatory Affairs Specialist pay dropped to $94,075 against a stable national figure near $104,000, even as national intelligence flags regulatory affairs as an acute bottleneck with VP-level roles commanding $320K-$580K. Current conditions suggest fewer senior postings are clearing the local market, not that regulatory talent has become easier to source.
September layoffs hit BioMarin and Bristol Myers while 64% of surveyed biopharma organizations report active recruiting and 41% expect more openings. Consolidation is freeing talent in some functions while leaving manufacturing, CMC, and regulatory roles under sustained pressure — a dynamic Albany employers should expect to see mirrored locally.
Local median pay of $119,600 against a national $108,377 median, both trending up, may reflect Albany's manufacturing and quality infrastructure competing directly against CDMO capacity elsewhere in the Northeast. Worth benchmarking this role proactively rather than waiting for attrition to reveal a gap.
Local Labor Conditions
Albany-Schenectady-Troy's labor market cooled further in 2026, averaging a net loss of 250 jobs per month against a 2025 pace of 267 monthly gains, the weakest reading since 2020, even as county unemployment held low at 3.9% in Albany and Rensselaer. Life sciences bucked the broader metro stall: New York's pharma and biotech workforce hit a record 23,643 jobs statewide in August, but BioSpace postings fell 39% year-over-year, pointing to an employer base that is hiring selectively rather than expansively.
Leadership & Talent Implications
Metro-wide softening gives leaders some relative leverage on general staffing, but it does not extend to credentialed scientific and regulatory roles — local Clinical Research Associate pay rose to a $99,791 median and Validation Engineer pay climbed to $119,600, both outpacing national movement, signaling continued competition for execution-critical functions even as postings volume declines. Falling Regulatory Affairs Specialist and Clinical Data Manager pay locally may reflect fewer but more senior postings rather than softening demand, which complicates build-vs-outsource math if internal benchmarking relies on raw postings trends alone. Consider reviewing role-level advertised pay against national movement before assuming Albany's cooler headline numbers translate into easier hiring for regulatory, quality, or manufacturing-adjacent talent.
Advertised Pay Indicators
| Role | P25 | Median | P75 | Local Trend | National | Nat. Trend |
|---|---|---|---|---|---|---|
| Research Scientist | $86,366 | $133,986 | $151,648 | ↑ Significant increase | $131,354 | ↑ Significant increase |
| Clinical Research Associate | $81,298 | $99,791 | $114,821 | ↑ Significant increase | $90,956 | ↑ Significant increase |
| Lab Technician | $43,690 | $45,363 | $50,960 | ↓ Moderate decline | $47,402 | ↓ Moderate decline |
| Regulatory Affairs Specialist | $68,284 | $94,075 | $114,913 | ↓ Moderate decline | $104,000 | → Stable |
| Clinical Data Manager | $103,544 | $122,660 | $136,385 | ↓ Significant decline | $123,031 | ↓ Moderate decline |
| Biostatistician | $107,702 | $131,963 | $163,353 | → Stable | $133,322 | ↑ Moderate increase |
| Validation Engineer | $98,050 | $119,600 | $121,586 | ↑ Significant increase | $108,377 | ↑ Moderate increase |
Looking Ahead · Next 30–60 Days
Worth watching
BioSpace postings down 39% year-over-year statewide could mean either reduced headcount plans or more targeted, senior-level requisitions. Track whether Albany-specific postings volume recovers alongside national Indeed Job Postings Index gains, now at 103.5 and rising.
Emerging pressure point
New York's 46 WARN notices over the past 90 days concentrated in healthcare, manufacturing, and transportation could release adjacent talent into the Albany life sciences candidate pool, particularly for quality and manufacturing-adjacent roles. Watch whether displaced manufacturing workers show credentials transferable to CMC or validation functions.
Potential inflection point
National GLP-1 pipeline expansion continues pulling manufacturing, quality, and regulatory talent toward specialists, a dynamic that directly affects CDMO capacity Albany-area manufacturers may rely on. Monitor whether build-vs-outsource tradeoffs shift as CDMO pricing power grows alongside scarcity-driven premiums.
Expected
October's first official September 2026 metro employment release will clarify whether Albany's 250-job average monthly loss is stabilizing or deepening. A continued decline alongside tight life sciences hiring would sharpen the contrast between general metro softness and sector-specific talent competition.
WageScape Member Benefit
Your Pulse covers one metro and one function or industry. Add coverage if you want to see the latest intelligence for other markets, industries, or functions.
Pulse Plus
3 metro reports
$149/year
Pulse Pro
10 metro reports
$349/year
Enterprise
10+ markets
Contact us
WageTrak · 15% Member Discount
On-demand advertised pay data across thousands of job titles, all metro areas, full percentile coverage, and monthly updates. Use code WAGESCAPE15 at wagetrak.com.
Forwarded This Briefing?
Receive your own personalized monthly briefing, filtered to your local market. Scan to enroll below.